Hosted on MSN

Prestige Consumer Healthcare outlines $1.1B-$1.115B FY26 revenue target amid Pillar5 acquisition and Clear Eyes supply recovery

Earnings Call Insights: Prestige Consumer Healthcare Inc. (PBH) Q1 2026 CEO Ronald M. Lombardi stated the quarter's sales were approximately $250 million, missing the $258 million to $260 million ...
Seeking Alpha

Prestige Consumer Healthcare narrows fiscal 2026 revenue outlook to $1.1B while advancing Clear Eyes supply recovery

Ron Lombardi, Chairman, President & CEO, stated the company delivered solid results for the third quarter, highlighting, "Sales of $283 million were slightly better than forecast. Our diverse customer ...
Yahoo

The latest eye medicine to be recalled: 715,000 bottles of Clear Eyes eye drops

Add Yahoo as a preferred source to see more of our stories on Google. Five lots of Clear Eyes eye drops have been recalled by Teva Pharmaceuticals, the latest in a run of recalls of prescription and ...
AOL

The latest eye medicine to be recalled: 715,000 bottles of Clear Eyes eye drops

Five lots of Clear Eyes eye drops have been recalled by Teva Pharmaceuticals, the latest in a run of recalls of prescription and over-the-counter eye medications. The FDA posting of the recall says ...